☰

Diane Brisson, Ph.D. - Publications

Affiliations: 
2005 Universite Laval (Canada) 
Area:
Genetics
Tree Info Similar researchers PubMed Report error

133 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Larouche M, Khoury E, Brisson D, Gaudet D. Inhibition of Angiopoietin-Like Protein 3 or 3/8 Complex and ApoC-III in Severe Hypertriglyceridemia. Current Atherosclerosis Reports. 25: 1101-1111. PMID 38095804 DOI: 10.1007/s11883-023-01179-y  0.389
2023 Lauzière A, Brisson D, Tremblay G, Bédard S, Khoury E, Gaudet D. Comparison of the burden of familial hypercholesterolemia between two cohorts of French Canadians hospitalized 25 years apart for coronary heart disease. Journal of Clinical Lipidology. PMID 38030518 DOI: 10.1016/j.jacl.2023.10.008  0.486
2023 Larouche M, Brisson D, Morissette MC, Gaudet D. Post-prandial analysis of fluctuations in the platelet count and platelet function in patients with the familial chylomicronemia syndrome. Orphanet Journal of Rare Diseases. 18: 167. PMID 37370069 DOI: 10.1186/s13023-023-02743-0  0.455
2023 Brisson D, Larouche M, Chebli J, Khoury E, Gaudet D. Correlation between chylomicronemia diagnosis scores and post-heparin lipoprotein lipase activity. Clinical Biochemistry. 114: 67-72. PMID 36780934 DOI: 10.1016/j.clinbiochem.2023.02.002  0.489
2022 Sun CJ, McCudden C, Brisson D, Shaw J, Gaudet D, Ooi TC. Comparison of three methods for LDLC calculation for cardiovascular disease risk categorization in three distinct patient populations. The Canadian Journal of Cardiology. PMID 36586484 DOI: 10.1016/j.cjca.2022.12.025  0.401
2022 Roy N, Gaudet D, Brisson D. Palmar Striated Xanthomas in Clinical Practice. Journal of the Endocrine Society. 6: bvac103. PMID 35860753 DOI: 10.1210/jendso/bvac103  0.463
2022 Sun CJ, Brisson D, Sharma R, Birkett N, Gaudet D, Ooi TC. A More Atherogenic Lipoprotein Status Is Present in Adults With Than Without Type 2 Diabetes Mellitus With Equivalent Degrees of Hypertriglyceridemia. Canadian Journal of Diabetes. PMID 35718690 DOI: 10.1016/j.jcjd.2022.02.001  0.46
2021 Roy G, Couture P, Genest J, Ruel I, Baass A, Bergeron J, Brisson D, Brunham LR, Cermakova L, Gaudet D, Khoury E, Laflamme N, Kennedy BA, Hegele RA, Drouin-Chartier JP. Influence of the LDL-receptor genotype on statin response in heterozygous familial hypercholesterolemia: insights from the Canadian FH Registry. The Canadian Journal of Cardiology. PMID 34774719 DOI: 10.1016/j.cjca.2021.10.013  0.46
2021 Bchetnia M, Bouchard L, Mathieu J, Campeau P, Morin C, Brisson D, Laberge AM, Vézina H, Gaudet D, Laprise C. Genetic burden linked to founder effects in Saguenay-Lac-Saint-Jean illustrates the importance of genetic screening test availability. Journal of Medical Genetics. PMID 33910931 DOI: 10.1136/jmedgenet-2021-107809  0.407
2021 Maltais M, Brisson D, Gaudet D. Non-Alcoholic Fatty Liver in Patients with Chylomicronemia. Journal of Clinical Medicine. 10. PMID 33572376 DOI: 10.3390/jcm10040669  0.473
2020 Khoury E, Brisson D, Roy N, Tremblay G, Gaudet D. Identifying Markers of Cardiovascular Event-Free Survival in Familial Hypercholesterolemia. Journal of Clinical Medicine. 10. PMID 33375401 DOI: 10.3390/jcm10010064  0.482
2020 Sun CJ, Brisson D, Gaudet D, Ooi TC. Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markers. Journal of Clinical Lipidology. PMID 33032940 DOI: 10.1016/j.jacl.2020.09.006  0.473
2020 Aljenedil S, Alothman L, Bélanger AM, Brown L, Lahijanian Z, Bergeron J, Couture P, Baass A, Ruel I, Brisson D, Khoury E, Gaudet D, Genest J. Lomitapide for treatment of homozygous familial hypercholesterolemia: The Québec experience. Atherosclerosis. 310: 54-63. PMID 32906018 DOI: 10.1016/J.Atherosclerosis.2020.07.028  0.547
2020 Tremblay K, Brisson D, Gaudet D. Gene expression profiles of recurrent acute pancreatitis risk in patients with sustained chylomicronemia. Endocrine Journal. PMID 32727960 DOI: 10.1507/Endocrj.Ej20-0123  0.499
2020 Tremblay K, Gaudet D, Khoury E, Brisson D. Dissection of Clinical and Gene Expression Signatures of Familial versus Multifactorial Chylomicronemia. Journal of the Endocrine Society. 4: bvaa056. PMID 32537545 DOI: 10.1210/Jendso/Bvaa056  0.538
2020 Roy N, Gaudet D, Tremblay G, Brisson D. Association of common gene-smoking interactions with elevated plasma apolipoprotein B concentration. Lipids in Health and Disease. 19: 98. PMID 32430061 DOI: 10.1186/S12944-020-01287-7  0.559
2020 Sun CJ, McCudden C, Brisson D, Shaw J, Gaudet D, Ooi TC. Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia. Journal of the Endocrine Society. 4: bvz010. PMID 32010872 DOI: 10.1210/Jendso/Bvz010  0.533
2020 Khoury E, Brisson D, Gaudet D. Preclinical discovery and development of evolocumab for the treatment of hypercholesterolemia. Expert Opinion On Drug Discovery. 1-12. PMID 31973581 DOI: 10.1080/17460441.2020.1704728  0.548
2020 Sun C, Brisson D, McCudden C, Shaw J, Gaudet D, Ooi T. Comparison of the Effect of Hypertriglyceridemia on Non-HDL-Cholesterol and Apolipoprotein B as Cardiovascular Disease Risk Markers∗,† Journal of Clinical Lipidology. 14: 571-572. DOI: 10.1016/J.Jacl.2020.05.047  0.526
2019 Guay SP, Houde AA, Breton E, Baillargeon JP, Perron P, Gaudet D, Hivert MF, Brisson D, Bouchard L. DNA methylation at gene locus mediates the association between maternal total cholesterol changes in pregnancy and cord blood leptin levels. Journal of Developmental Origins of Health and Disease. 1-10. PMID 31753053 DOI: 10.1017/S204017441900076X  0.539
2019 Floyd JS, Bloch KM, Brody JA, Maroteau C, Siddiqui MK, Gregory R, Carr DF, Molokhia M, Liu X, Bis JC, Ahmed A, Liu X, Hallberg P, Yue QY, Magnusson PKE, ... Brisson D, et al. Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing. Plos One. 14: e0218115. PMID 31242253 DOI: 10.1371/Journal.Pone.0218115  0.475
2019 Khoury E, Brisson D, Roy N, Tremblay G, Gaudet D. Review of the long-term safety of lomitapide: a microsomal triglycerides transfer protein inhibitor for treating homozygous familial hypercholesterolemia. Expert Opinion On Drug Safety. PMID 30945578 DOI: 10.1080/14740338.2019.1602606  0.541
2019 Lauziere A, Brisson D, Bedard S, Khoury E, Tremblay G, Barabas M, Gaudet D. 4944The contribution of familial hypercholesterolemia (FH) to premature coronary artery disease decreased by 2-fold between 1998 and 2018 in a founder population with high prevalence of FH European Heart Journal. 40. DOI: 10.1093/Eurheartj/Ehz746.0014  0.536
2019 Brisson D, Khoury E, Gaudet D. Free glycerol correlate with post-heparin lipoprotein lipase activity and contribute to differentiate familial vs. multifactorial chylomicronemia Journal of Clinical Lipidology. 13: e26. DOI: 10.1016/J.Jacl.2019.04.047  0.499
2019 Khoury E, Gaudet D, Brisson D. Correlation between chylomicronemia diagnosis scores and post-heparin lipoprotein lipase activity Journal of Clinical Lipidology. 13: e25-e26. DOI: 10.1016/J.Jacl.2019.04.046  0.467
2019 Carpentier AC, Frisch F, Brisson D, Gaudet D. Familial Chylomicronemia Syndrome is associated with increased dietary fatty acid spillover in the circulation despite lower total postprandial triglycerides Journal of Clinical Lipidology. 13: e25. DOI: 10.1016/J.Jacl.2019.04.045  0.503
2018 Ruel I, Brisson D, Aljenedil S, Awan Z, Baass A, Bélanger A, Bergeron J, Bewick D, Brophy JM, Brunham LR, Couture P, Dufour R, Francis GA, Frohlich J, Gagné C, et al. Simplified Canadian Definition for Familial Hypercholesterolemia. The Canadian Journal of Cardiology. PMID 30093300 DOI: 10.1016/J.Cjca.2018.05.015  0.547
2018 Tremblay M, Brisson D, Gaudet D. Association study between a polymorphic poly-T repeat sequence in the promoter of the somatostatin gene and metabolic syndrome. Bmc Medical Genetics. 19: 130. PMID 30053852 DOI: 10.1186/S12881-018-0641-6  0.543
2018 Dron JS, Wang J, Berberich AJ, Iacocca MA, Cao H, Yang P, Knoll J, Tremblay K, Brisson D, Netzer C, Gouni-Berthold I, Gaudet D, Hegele RA. Large-scale deletions of the ABCA1 gene in patients with hypoalphalipoproteinemia. Journal of Lipid Research. PMID 29866657 DOI: 10.1194/Jlr.P086280  0.552
2018 Cardenas A, Gagné-Ouellet V, Allard C, Brisson D, Perron P, Bouchard L, Hivert MF. Placenta DNA Methylation Adaptation to Maternal Glycemic Response in Pregnancy. Diabetes. PMID 29752424 DOI: 10.2337/Db18-0123  0.327
2018 Ooi TC, Gaudet D, Brisson D, Tepliakova L, Figeys D, Mayne J. Circulating Soluble Low Density Lipoprotein Receptor Levels in Heterozygous Familial Hypercholesterolemia Subjects Before and After Statin Therapy Atherosclerosis Supplements. 32: 60-61. DOI: 10.1016/J.Atherosclerosissup.2018.04.182  0.514
2018 Brisson D, Tremblay K, Gaudet D. A Simple Clinical Diagnosis Scoring System Allowing to Identify Familial Form of Chylomicronemia Syndrome Atherosclerosis Supplements. 32: 57-58. DOI: 10.1016/J.Atherosclerosissup.2018.04.173  0.478
2018 Aljenedil S, Ruel I, Brisson D, Awan Z, Baass A, Bélanger A, Bewick D, Bergeron J, Brophy JM, Brunham LR, Couture P, Dufour R, Francis GA, Frohlich J, Gagné C, et al. Canadian Definition for Familial Hypercholesterolemia Atherosclerosis Supplements. 32: 55-56. DOI: 10.1016/J.Atherosclerosissup.2018.04.167  0.469
2018 Khoury E, Brisson D, Roy N, Tremblay G, Gaudet D. Surviving Familial Hypercholesterolemia without Coronary Artery Disease: A Unique Phenomenon Associated with Newly Identified Biological and Genetic Markers Atherosclerosis Supplements. 32: 51. DOI: 10.1016/J.Atherosclerosissup.2018.04.154  0.502
2018 Tremblay K, Brisson D, Gaudet D. Long-term Post LPL Gene Replacement Therapy Gene Expression Profile in Patients with Complete LPL Deficiency Atherosclerosis Supplements. 32: 50. DOI: 10.1016/J.Atherosclerosissup.2018.04.149  0.506
2018 Tremblay K, Brisson D, Gaudet D. Lipoprotein lipase gene replacement therapy long-term effect on familial hyperchylomicronemia gene expression profile Atherosclerosis. 275: e34. DOI: 10.1016/J.Atherosclerosis.2018.06.086  0.528
2017 Tremblay K, Brisson D, Gaudet D. Natural history and gene expression signature of platelet count in lipoprotein lipase deficiency. Atherosclerosis. 263: e100. PMID 29365429 DOI: 10.1016/J.Atherosclerosis.2017.06.325  0.513
2017 Ruel I, Aljenedil S, Sadri I, de Varennes É, Hegele RA, Couture P, Bergeron J, Wanneh E, Baass A, Dufour R, Gaudet D, Brisson D, Brunham LR, Francis GA, Cermakova L, et al. Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe. Clinical Chemistry. PMID 29038147 DOI: 10.1373/Clinchem.2017.279422  0.568
2017 Paquette M, Brisson D, Dufour R, Khoury É, Gaudet D, Baass A. Cardiovascular disease in familial hypercholesterolemia: Validation and refinement of the Montreal-FH-SCORE. Journal of Clinical Lipidology. PMID 28801029 DOI: 10.1016/J.Jacl.2017.07.008  0.524
2017 Gaudet D, Gipe DA, Pordy R, Ahmad Z, Cuchel M, Shah PK, Chyu KY, Sasiela WJ, Chan KC, Brisson D, Khoury E, Banerjee P, Gusarova V, Gromada J, Stahl N, et al. ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia. The New England Journal of Medicine. 377: 296-297. PMID 28723334 DOI: 10.1056/Nejmc1705994  0.495
2017 Gagné-Ouellet V, Houde AA, Guay SP, Perron P, Gaudet D, Guérin R, Baillargeon JP, Hivert MF, Brisson D, Bouchard L. Placental lipoprotein lipase DNA methylation alterations are associated with gestational diabetes and body composition at 5 years of age. Epigenetics. 0. PMID 28486003 DOI: 10.1080/15592294.2017.1322254  0.502
2017 Gaudet D, Baass A, Tremblay K, Brisson D, Laflamme N, Paquette M, Dufour R, Bergeron J. Natural History (up to 15 years) of Platelet Count in 84 Patients with Familial Hyperchylomicronemia Due to Lipoprotein Lipase Deficiency Journal of Clinical Lipidology. 11: 797-798. DOI: 10.1016/J.Jacl.2017.04.043  0.495
2017 Tremblay K, Brisson D, Gaudet D. Gene Expression Signature of Platelet Count in Lipoprotein Lipase Deficiency Journal of Clinical Lipidology. 11: 795. DOI: 10.1016/J.Jacl.2017.04.039  0.511
2017 Baass A, Paquette M, Brisson D, Dufour R, Gaudet D. Predicting Cardiovascular Events in Familial Hypercholesterolemia: Validation of the Montreal-FH-SCORE Journal of Clinical Lipidology. 11: 781. DOI: 10.1016/J.Jacl.2017.04.018  0.473
2016 Gaudet D, Stroes ES, Methot J, Brisson D, Tremblay K, Bernelot Moens SJ, Iotti G, Rastelletti I, Ardigo D, Corzo D, Meyer C, Andersen M, Ruszniewski P, Deakin M, Bruno MJ. A Long-Term (up to 6 years) Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and its Effect on Lipoprotein Lipase Deficiency (LPLD)-Induced Pancreatitis. Human Gene Therapy. PMID 27412455 DOI: 10.1089/Hum.2015.158  0.522
2016 Côté S, Gagné-Ouellet V, Guay SP, Allard C, Houde AA, Perron P, Baillargeon JP, Gaudet D, Guérin R, Brisson D, Hivert MF, Bouchard L. PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns. Clinical Epigenetics. 8: 72. PMID 27340502 DOI: 10.1186/S13148-016-0239-9  0.519
2016 Besseling J, Reitsma JB, Gaudet D, Brisson D, Kastelein JJ, Hovingh GK, Hutten BA. Selection of individuals for genetic testing for familial hypercholesterolaemia: development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemia. European Heart Journal. PMID 27044878 DOI: 10.1093/Eurheartj/Ehw135  0.494
2016 Guay SP, Légaré C, Brisson D, Mathieu P, Bossé Y, Gaudet D, Bouchard L. Epigenetic and genetic variations at the TNNT1 gene locus are associated with HDL-C levels and coronary artery disease. Epigenomics. 8: 359-71. PMID 26950807 DOI: 10.2217/Epi.15.120  0.561
2016 Tremblay M, Brisson D, Gaudet D. Association between a polymorphic poly-T repeat sequence in the promoter of the somatostatin gene and hypertension. Hypertension Research : Official Journal of the Japanese Society of Hypertension. 39: 467-74. PMID 26818653 DOI: 10.1038/Hr.2016.4  0.496
2016 Tremblay K, Brisson D, Gaudet D. Gene Expression Signature of Recurrent Acute Pancreatitis Risk in LPL Deficiency and Severe Hypertriglyceridemia Journal of Clinical Lipidology. 10: 681. DOI: 10.1016/J.Jacl.2016.03.049  0.504
2016 Roy N, Gaudet D, Brisson D. Association Between Frequent Gene-Smoking Interactions And Plama Apolipoprotein B Levels Among Low-Risk Individuals Journal of Clinical Lipidology. 10: 671-672. DOI: 10.1016/J.Jacl.2016.03.039  0.499
2016 Khoury E, Brisson D, Roy N, Tremblay K, Tremblay G, Gaudet D. Environmental and Biological Markers of Survival in Septuagenarians and Octogenarians Carrying FH-Causing LDLR Gene Mutations* Journal of Clinical Lipidology. 10: 671. DOI: 10.1016/J.Jacl.2016.03.038  0.482
2016 Gaudet D, Brisson D, Tremblay K. Genetic and Functional investigation of LPL Independent Pathways of TG-Rich Lipoproteins Catabolism in Severe Hypertriglyceridemia and Chylomicronemia Journal of Clinical Lipidology. 10: 664. DOI: 10.1016/J.Jacl.2016.03.028  0.505
2016 Gaudet D, Brisson D, Tremblay K. Investigation of LPL independent pathways of TG-rich lipoprotein metabolism in LPL deficiency Atherosclerosis. 252: e120. DOI: 10.1016/J.Atherosclerosis.2016.07.637  0.509
2015 Gaudet D, Brisson D. Gene-based therapies in lipidology: current status and future challenges. Current Opinion in Lipidology. 26: 553-65. PMID 26780008 DOI: 10.1097/Mol.0000000000000240  0.512
2015 Villeneuve S, Brisson D, Gaudet D. Influence of Abdominal Obesity on the Lipid-Lipoprotein Profile in Apoprotein E2/4 Carriers: The Effect of an Apparent Duality. Journal of Lipids. 2015: 742408. PMID 26605088 DOI: 10.1155/2015/742408  0.528
2015 Houde AA, Ruchat SM, Allard C, Baillargeon JP, St-Pierre J, Perron P, Gaudet D, Brisson D, Hivert MF, Bouchard L. LRP1B, BRD2 and CACNA1D: new candidate genes in fetal metabolic programming of newborns exposed to maternal hyperglycemia. Epigenomics. PMID 26586120 DOI: 10.2217/Epi.15.72  0.688
2015 Gaudet D, Alexander VJ, Baker BF, Brisson D, Tremblay K, Singleton W, Geary RS, Hughes SG, Viney NJ, Graham MJ, Crooke RM, Witztum JL, Brunzell JD, Kastelein JJ. Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia. The New England Journal of Medicine. 373: 438-47. PMID 26222559 DOI: 10.1056/Nejmoa1400283  0.518
2015 Guay SP, Brisson D, Mathieu P, Bossé Y, Gaudet D, Bouchard L. A study in familial hypercholesterolemia suggests reduced methylomic plasticity in men with coronary artery disease. Epigenomics. 7: 17-34. PMID 25687463 DOI: 10.2217/Epi.14.64  0.494
2015 Gaudet D, Brisson D. Gene-based therapies in lipidology: Current status and future challenges Current Opinion in Lipidology. 26: 553-565. DOI: 10.1097/MOL.0000000000000240  0.416
2015 Bernelot Moens SJ, Stroes ES, Andersen M, Meyer C, Brisson D, Bruno M, Gaudet D. Effect of gene therapy with alipogene tiparvovec on the incidence of pancreatitis in patients with lipoprotein lipase deficiency Pancreatology. 15: S53-S54. DOI: 10.1016/J.Pan.2015.05.212  0.524
2015 Bernelot-Moens S, Stroes E, Carpentier A, Brisson D, Andersen M, Meyer C, Bruno M, Gaudet D. Gene therapy for lipoprotein lipase deficiency (LPLD): Final results of 3 prospective gene therapy clinical studies and 1 retrospective clinical events analysis Atherosclerosis. 241: e26. DOI: 10.1016/J.Atherosclerosis.2015.04.100  0.513
2014 Gaudet D, Brisson D, Tremblay K, Alexander VJ, Singleton W, Hughes SG, Geary RS, Baker BF, Graham MJ, Crooke RM, Witztum JL. Targeting APOC3 in the familial chylomicronemia syndrome. The New England Journal of Medicine. 371: 2200-6. PMID 25470695 DOI: 10.1056/Nejmoa1400284  0.552
2014 Villeneuve S, Brisson D, Marchant NL, Gaudet D. The potential applications of Apolipoprotein E in personalized medicine. Frontiers in Aging Neuroscience. 6: 154. PMID 25071563 DOI: 10.3389/Fnagi.2014.00154  0.5
2014 Houde AA, St-Pierre J, Hivert MF, Baillargeon JP, Perron P, Gaudet D, Brisson D, Bouchard L. Placental lipoprotein lipase DNA methylation levels are associated with gestational diabetes mellitus and maternal and cord blood lipid profiles. Journal of Developmental Origins of Health and Disease. 5: 132-41. PMID 24847699 DOI: 10.1017/S2040174414000038  0.693
2014 Desgagné V, Hivert MF, St-Pierre J, Guay SP, Baillargeon JP, Perron P, Gaudet D, Brisson D, Bouchard L. Epigenetic dysregulation of the IGF system in placenta of newborns exposed to maternal impaired glucose tolerance. Epigenomics. 6: 193-207. PMID 24811788 DOI: 10.2217/Epi.14.3  0.662
2014 Tremblay K, Dubois-Bouchard C, Brisson D, Gaudet D. Association of CTRC and SPINK1 gene variants with recurrent hospitalizations for pancreatitis or acute abdominal pain in lipoprotein lipase deficiency. Frontiers in Genetics. 5: 90. PMID 24795752 DOI: 10.3389/Fgene.2014.00090  0.536
2014 Guay SP, Brisson D, Lamarche B, Biron S, Lescelleur O, Biertho L, Marceau S, Vohl MC, Gaudet D, Bouchard L. ADRB3 gene promoter DNA methylation in blood and visceral adipose tissue is associated with metabolic disturbances in men. Epigenomics. 6: 33-43. PMID 24579945 DOI: 10.2217/Epi.13.82  0.513
2014 Guay SP, Brisson D, Lamarche B, Gaudet D, Bouchard L. Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia. Epigenetics : Official Journal of the Dna Methylation Society. 9: 718-29. PMID 24504152 DOI: 10.4161/Epi.27981  0.592
2014 Ferreira V, Twisk J, Kwikkers K, Aronica E, Brisson D, Methot J, Petry H, Gaudet D. Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy. Human Gene Therapy. 25: 180-8. PMID 24299335 DOI: 10.1089/Hum.2013.169  0.483
2014 Tremblay M, Bouhali T, Gaudet D, Brisson D. Genealogical analysis as a new approach for the investigation of drug intolerance heritability. European Journal of Human Genetics : Ejhg. 22: 916-22. PMID 24281370 DOI: 10.1038/Ejhg.2013.270  0.51
2014 Tremblay K, Dubois-Bouchard C, Brisson D, Gaudet D. Pancreatitis in Severe Hypertriglyceridemia: Association of Gene Variants in Lipoprotein Lipase and Serine Protease Pathways with Increased Risk of Recurrent Hospitalizations* Journal of Clinical Lipidology. 8: 312. DOI: 10.1016/J.Jacl.2014.02.034  0.535
2014 Tremblay K, Dubois-Bouchard C, Brisson D, Gaudet D. Polymorphisms in protease-regulating genes are associated with recurrence of hospitalizations for acute abdominal pain in lipoprotein lipase deficiency Atherosclerosis. 235: e58. DOI: 10.1016/J.Atherosclerosis.2014.05.143  0.491
2013 Houde AA, Guay SP, Desgagné V, Hivert MF, Baillargeon JP, St-Pierre J, Perron P, Gaudet D, Brisson D, Bouchard L. Adaptations of placental and cord blood ABCA1 DNA methylation profile to maternal metabolic status. Epigenetics : Official Journal of the Dna Methylation Society. 8: 1289-302. PMID 24113149 DOI: 10.4161/Epi.26554  0.689
2013 Ruchat SM, Houde AA, Voisin G, St-Pierre J, Perron P, Baillargeon JP, Gaudet D, Hivert MF, Brisson D, Bouchard L. Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases. Epigenetics : Official Journal of the Dna Methylation Society. 8: 935-43. PMID 23975224 DOI: 10.4161/Epi.25578  0.698
2013 Hayes MG, Urbanek M, Hivert MF, Armstrong LL, Morrison J, Guo C, Lowe LP, Scheftner DA, Pluzhnikov A, Levine DM, McHugh CP, Ackerman CM, Bouchard L, Brisson D, Layden BT, et al. Identification of HKDC1 and BACE2 as genes influencing glycemic traits during pregnancy through genome-wide association studies. Diabetes. 62: 3282-91. PMID 23903356 DOI: 10.2337/Db12-1692  0.347
2013 Brisson D, Perron P, Kahn HS, Gaudet D, Bouchard L. The lipid accumulation product for the early prediction of gestational insulin resistance and glucose dysregulation. Journal of Women's Health (2002). 22: 362-7. PMID 23717842 DOI: 10.1089/Jwh.2012.3807  0.486
2013 Guay SP, Brisson D, Lamarche B, Marceau P, Vohl MC, Gaudet D, Bouchard L. DNA methylation variations at CETP and LPL gene promoter loci: new molecular biomarkers associated with blood lipid profile variability. Atherosclerosis. 228: 413-20. PMID 23623643 DOI: 10.1016/J.Atherosclerosis.2013.03.033  0.572
2013 Gaudet D, Signorovitch J, Swallow E, Fan L, Tremblay K, Brisson D, Meyers C, Gruenberger JB. Medical resource use and costs associated with chylomicronemia. Journal of Medical Economics. 16: 657-66. PMID 23428107 DOI: 10.3111/13696998.2013.779277  0.495
2013 Gagnon C, Chouinard MC, Laberge L, Brisson D, Gaudet D, Lavoie M, Leclerc N, Mathieu J. Prevalence of lifestyle risk factors in myotonic dystrophy type 1. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 40: 42-7. PMID 23250126 DOI: 10.1017/S0317167100012932  0.465
2013 Gaudet D, Méthot J, Déry S, Brisson D, Essiembre C, Tremblay G, Tremblay K, de Wal J, Twisk J, van den Bulk N, Sier-Ferreira V, van Deventer S. Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial. Gene Therapy. 20: 361-9. PMID 22717743 DOI: 10.1038/Gt.2012.43  0.537
2013 Guay SP, Gaudet D, Brisson D. The g.-469G>A polymorphism in the GPIHBP1 gene promoter is associated with hypertriglyceridemia and has an additive effect on the risk conferred by LPL defective alleles. Nutrition, Metabolism, and Cardiovascular Diseases : Nmcd. 23: 358-65. PMID 21978733 DOI: 10.1016/J.Numecd.2011.08.005  0.561
2013 Ruchat S, Houde A, St-Pierre J, Perron P, Baillargeon J, Gaudet D, Hivert M, Brisson D, Bouchard L. Gestational Diabetes Mellitus Epigenetically Predominantly Affects Genes Involved in Metabolic Diseases Canadian Journal of Diabetes. 37: S241. DOI: 10.1016/J.Jcjd.2013.03.150  0.521
2012 Guay SP, Voisin G, Brisson D, Munger J, Lamarche B, Gaudet D, Bouchard L. Epigenome-wide analysis in familial hypercholesterolemia identified new loci associated with high-density lipoprotein cholesterol concentration. Epigenomics. 4: 623-39. PMID 23244308 DOI: 10.2217/Epi.12.62  0.561
2012 Tremblay M, Brisson D, Gaudet D. Association between salivary pH and metabolic syndrome in women: a cross-sectional study. Bmc Oral Health. 12: 40. PMID 22958748 DOI: 10.1186/1472-6831-12-40  0.471
2012 St-Pierre J, Hivert MF, Perron P, Poirier P, Guay SP, Brisson D, Bouchard L. IGF2 DNA methylation is a modulator of newborn's fetal growth and development. Epigenetics : Official Journal of the Dna Methylation Society. 7: 1125-32. PMID 22907587 DOI: 10.4161/Epi.21855  0.604
2012 Carpentier AC, Frisch F, Labbé SM, Gagnon R, de Wal J, Greentree S, Petry H, Twisk J, Brisson D, Gaudet D. Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients. The Journal of Clinical Endocrinology and Metabolism. 97: 1635-44. PMID 22438229 DOI: 10.1210/Jc.2011-3002  0.531
2012 Mammen AL, Gaudet D, Brisson D, Christopher-Stine L, Lloyd TE, Leffell MS, Zachary AA. Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Care & Research. 64: 1233-7. PMID 22422616 DOI: 10.1002/Acr.21671  0.458
2012 Guay SP, Brisson D, Munger J, Lamarche B, Gaudet D, Bouchard L. ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia. Epigenetics : Official Journal of the Dna Methylation Society. 7: 464-72. PMID 22419126 DOI: 10.4161/Epi.19633  0.583
2012 Bouchard L, Hivert MF, Guay SP, St-Pierre J, Perron P, Brisson D. Placental adiponectin gene DNA methylation levels are associated with mothers' blood glucose concentration. Diabetes. 61: 1272-80. PMID 22396200 DOI: 10.2337/Db11-1160  0.618
2012 Tremblay M, Loucif Y, Methot J, Brisson D, Gaudet D. Salivary pH as a marker of plasma adiponectin concentrations in Women. Diabetology & Metabolic Syndrome. 4: 4. PMID 22304893 DOI: 10.1186/1758-5996-4-4  0.487
2012 Méthot J, Brisson D, Gaudet D. On-site management of investigational products and drug delivery systems in conformity with Good Clinical Practices (GCPs). Clinical Trials (London, England). 9: 265-71. PMID 22222352 DOI: 10.1177/1740774511431280  0.453
2012 Mammen AL, Pak K, Williams EK, Brisson D, Coresh J, Selvin E, Gaudet D. Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects. Arthritis Care & Research. 64: 269-72. PMID 21972203 DOI: 10.1002/Acr.20662  0.453
2011 Tremblay M, Gaudet D, Brisson D. Metabolic syndrome and oral markers of cardiometabolic risk. Journal (Canadian Dental Association). 77: b125. PMID 21975074  0.458
2011 Tremblay K, Méthot J, Brisson D, Gaudet D. Etiology and risk of lactescent plasma and severe hypertriglyceridemia. Journal of Clinical Lipidology. 5: 37-44. PMID 21262505 DOI: 10.1016/J.Jacl.2010.11.004  0.494
2011 Loucif Y, Méthot J, Tremblay K, Brisson D, Gaudet D. Contribution of adiponectin to the cardiometabolic risk of postmenopausal women with loss-of-function lipoprotein lipase gene mutations. Menopause (New York, N.Y.). 18: 558-62. PMID 21252727 DOI: 10.1097/Gme.0B013E3181Fca1D4  0.553
2011 Sirois-Gagnon D, Chamberland A, Perron S, Brisson D, Gaudet D, Laprise C. Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity. Obesity (Silver Spring, Md.). 19: 222-7. PMID 20523302 DOI: 10.1038/Oby.2010.125  0.497
2011 Greentree S, Méthot J, Déry S, Tremblay K, de Wal J, van den Bulk N, Ruiterkamp G, Freidig A, Brisson D, Gaudet D. 35 ALIPOGENE TIPARVOVEC GENE THERAPY SIGNIFICANTLY REDUCES THE RISK OF PANCREATITIS IN LIPOPROTEIN LIPASE DEFICIENT PATIENTS Atherosclerosis Supplements. 12: 8. DOI: 10.1016/S1567-5688(11)70036-8  0.537
2011 Carpentier A, Frisch F, Labbé S, Méthot J, Gagné C, Déry S, Tremblay K, de Wal J, Twisk J, Greentree S, van den Bulk N, Brisson D, Gaudet D. 8 ALIPOGENE TIPARVOVEC GENE THERAPY ENHANCES POST-PRANDIAL CLEARANCE OF CHYLOMICRONS IN LIPOPROTEIN LIPASE DEFICIENT PATIENTS Atherosclerosis Supplements. 12: 2. DOI: 10.1016/S1567-5688(11)70009-5  0.527
2011 Bouchard L, Guay S, St-Pierre J, Hivert M, Perron P, Brisson D. Placental adiponectin gene DNA methylation levels is correlated with maternal blood glucose concentration Canadian Journal of Diabetes. 35: 147-148. DOI: 10.1016/S1499-2671(11)52040-4  0.611
2010 Brisson D, Méthot J, Tremblay K, Tremblay M, Perron P, Gaudet D. Comparison of the efficacy of fibrates on hypertriglyceridemic phenotypes with different genetic and clinical characteristics. Pharmacogenetics and Genomics. 20: 742-7. PMID 21217359 DOI: 10.1097/Fpc.0B013E328340095E  0.496
2010 Gagnon C, Chouinard MC, Laberge L, Veillette S, Bégin P, Breton R, Jean S, Brisson D, Gaudet D, Mathieu J. Health supervision and anticipatory guidance in adult myotonic dystrophy type 1. Neuromuscular Disorders : Nmd. 20: 847-51. PMID 20884209 DOI: 10.1016/J.Nmd.2010.08.006  0.467
2010 van der Graaf A, Vissers MN, Gaudet D, Brisson D, Sivapalaratnam S, Roseboom TJ, Jansen AC, Kastelein JJ, Hutten BA. Dyslipidemia of mothers with familial hypercholesterolemia deteriorates lipids in adult offspring. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 2673-7. PMID 20864670 DOI: 10.1161/Atvbaha.110.209064  0.535
2010 Brisson D, Perron P, Guay SP, Gaudet D, Bouchard L. The "hypertriglyceridemic waist" phenotype and glucose intolerance in pregnancy. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 182: E722-5. PMID 20855478 DOI: 10.1503/Cmaj.100378  0.484
2010 Bouchard L, Thibault S, Guay SP, Santure M, Monpetit A, St-Pierre J, Perron P, Brisson D. Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy. Diabetes Care. 33: 2436-41. PMID 20724651 DOI: 10.2337/Dc10-1024  0.618
2010 Gaudet D, de Wal J, Tremblay K, Déry S, van Deventer S, Freidig A, Brisson D, Méthot J. Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency. Atherosclerosis. Supplements. 11: 55-60. PMID 20427244 DOI: 10.1016/J.Atherosclerosissup.2010.03.004  0.529
2010 Gaudet D, de Wal J, Brisson D, van den Bulk N, Greentree S, Méthot J. L7 RESULTS OF FIRST FOLLOW UP STUDY WITH GENE THERAPY WITH ALIPOGENE TIPARVOVEC (AMT-011) IN LIPOPROTEIN LIPASE DEFICIENCY (LPLD) Atherosclerosis Supplements. 11: 15. DOI: 10.1016/S1567-5688(10)70067-2  0.513
2010 Gaudet D, Frisch F, Méthot J, Gagné C, Déry S, Tremblay K, de Wal J, Twisk J, Brisson D, Carpentier A. Gene Therapy With Alipogene Tiparvovec Results in Enhanced Post-prandial Clearance of Chylomicrons in LPLD Patients Atherosclerosis Supplements. 11: 74. DOI: 10.1016/J.Atherosclerosissup.2010.04.025  0.498
2010 Gaudet D, Methot J, Brisson D, Dery S, van den Bulk N, Greentree S, Gagné C. Alipogene Tiparvovec May Prevent Pancreatitis From Chylomicronaemia in Lipoprotein Lipase Deficiency (LPLD) Atherosclerosis Supplements. 11: 73-74. DOI: 10.1016/J.Atherosclerosissup.2010.04.024  0.484
2009 Methot J, Bouhali T, Brisson D, Bouchard L, Tremblay G, Gaudet D. Abstract: P848 THE COMBINATION OF THE “HYPERTRIGLYCERIDEMIC WAIST” PHENOTYPE AND MENOPAUSE INCREASES CORONARY ARTERY DISEASE RISK AT A HIGHER LEVEL THAN DOES FAMILIAL HYPERCHOLESTEROLEMIA IN WOMEN Atherosclerosis Supplements. 10: e991. DOI: 10.1016/S1567-5688(09)70969-9  0.511
2009 van der Graaf A, Vissers M, Gaudet D, Brisson D, Sivapalaratnam S, Roseboom T, Janssen A, Kastelein J, Hutten B. Abstract: 1024 THE DYSLIPIDEMIA OF MOTHERS WITH FAMILIAL HYPERCHOLESTEROLEMIA DETERIORATES LIPID LEVELS IN THEIR ADULT OFFSPRING Atherosclerosis Supplements. 10: e391. DOI: 10.1016/S1567-5688(09)70383-6  0.502
2009 Methot J, Brisson D, Perron P, Gaudet D. Abstract: 1017 RELATION OF THE “HYPERTRIGLYCERIDEMIC WAIST” PHENOTYPE TO GLUCOSE INTOLERANCE AND TYPE 2 DIABETES IN POSTMENOPAUSAL WOMEN Atherosclerosis Supplements. 10: e388. DOI: 10.1016/S1567-5688(09)70380-0  0.469
2009 Gaudet D, Brisson D, Methot J, van Deventer S. Abstract: 554 AN OPEN-LABEL, DOSE ESCALATION STUDY TO ASSESS THE SAFETY AND EFFICACY OF AAV1-LPLS447X GENE THERAPY WITH ALIPOGENE TIPARVOVEC (AMT-011) FOR PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA DUE TO LIPOPROTEIN LIPASE DEFICIENCY (LPLD) Atherosclerosis Supplements. 10: e286. DOI: 10.1016/S1567-5688(09)70286-7  0.495
2008 Engert JC, Lemire M, Faith J, Brisson D, Fujiwara TM, Roslin NM, Brewer CG, Montpetit A, Darmond-Zwaig C, Renaud Y, Doré C, Bailey SD, Verner A, Tremblay G, St-Pierre J, et al. Identification of a chromosome 8p locus for early-onset coronary heart disease in a French Canadian population. European Journal of Human Genetics : Ejhg. 16: 105-14. PMID 17805225 DOI: 10.1038/Sj.Ejhg.5201920  0.679
2008 Bouhali T, Brisson D, St-Pierre J, Tremblay G, Perron P, Laprise C, Vohl MC, Vissers MN, Hutten BA, Després JP, Kastelein JJ, Gaudet D. Low plasma adiponectin exacerbates the risk of premature coronary artery disease in familial hypercholesterolemia. Atherosclerosis. 196: 262-9. PMID 17123536 DOI: 10.1016/J.Atherosclerosis.2006.10.035  0.694
2007 Perron P, Brisson D, Santuré M, Blackburn P, Bergeron J, Vohl MC, Després JP, Gaudet D. Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes. Journal of Endocrinological Investigation. 30: 551-7. PMID 17848837 DOI: 10.1007/Bf03346348  0.569
2007 Pare G, Serre D, Brisson D, Anand SS, Montpetit A, Tremblay G, Engert JC, Hudson TJ, Gaudet D. Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol. American Journal of Human Genetics. 80: 673-82. PMID 17357073 DOI: 10.1086/513286  0.559
2007 Brisson D, St-Pierre J, Santuré M, Hudson TJ, Després JP, Vohl MC, Gaudet D. Genetic epistasis in the VLDL catabolic pathway is associated with deleterious variations on triglyceridemia in obese subjects. International Journal of Obesity (2005). 31: 1325-33. PMID 17342071 DOI: 10.1038/Sj.Ijo.0803586  0.519
2007 St-Pierre J, Lemieux I, Perron P, Brisson D, Santuré M, Vohl MC, Després JP, Gaudet D. Relation of the "hypertriglyceridemic waist" phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus. The American Journal of Cardiology. 99: 369-73. PMID 17261400 DOI: 10.1016/J.Amjcard.2006.08.041  0.687
2006 Bouhali T, Brisson D, Tremblay G, Perron P, Vohl M, Despres J, Vissers M, Hutten B, Kastelein J, Gaudet D. Th-W58:6 Combined effect of adiponectin and HDL-cholesterol on premature coronary artery disease risk in familial hypercholesterolemia and other dyslipidemias Atherosclerosis Supplements. 7: 484. DOI: 10.1016/S1567-5688(06)81934-3  0.532
2006 Perron P, Brisson D, Santure M, Blackburn P, Despres J, Gaudet D. We-W30:5 Epistatic effect of frequent apolipoprotein E and lipoprotein lipase gene variants on hypertrigly ceridemia hyperapobetalipoproteinemia expression Atherosclerosis Supplements. 7: 306. DOI: 10.1016/S1567-5688(06)81230-4  0.523
2006 Santure M, Brisson D, Tremblay G, Lamarche B, Gaudet D. Tu-W27:6 Relationship between triglyceride-enriched HDL particles and intolerance to statin therapy Atherosclerosis Supplements. 7: 175. DOI: 10.1016/S1567-5688(06)80681-1  0.486
2006 Engert J, Pare G, Lemire M, Faith J, Brisson D, Vohl M, Tremblay G, Hudson T, Gaudet D. Mo-P6:391 Identification of a chromosome 8P locus for coronary heart disease in the French Canadian founder population Atherosclerosis Supplements. 7: 131-132. DOI: 10.1016/S1567-5688(06)80521-0  0.462
2005 Brisson D, Mathieu J, Vohl MC, Gaudet D. Presence of palmar xanthomas in myotonic dystrophy identifies different patterns of linkage disequilibrium between the apolipoprotein E and myotonic dystrophy protein kinase loci. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 7: 213-5. PMID 15775763 DOI: 10.1097/01.Gim.0000157130.81975.Fe  0.448
2005 Bouhali T, Brisson D, Tremblay G, Gagne C, Couture P, Vissers M, Hutten B, Kastelein J, Gaudet D. W08-O-001 Familial hypercholesterolemia patients with coronary artery disease Atherosclerosis Supplements. 6: 29. DOI: 10.1016/S1567-5688(05)80114-X  0.477
2003 Gaudet D, Vohl M, Brisson D, Connely P, Hamet P, Hudson T, Laberge C, Laprise C. 2P-0353 Prevalence and geographic distribution of a frequent genotypic combination of hyperapo B in the Quebec population Atherosclerosis Supplements. 4: 116. DOI: 10.1016/S1567-5688(03)90496-X  0.438
2003 Gaudet D, Perron P, Saint-Pierre J, Brisson D, Russe L, Bergeron J, Rioux J, Vohl M, Hudson T. 2HT01-3 Glycerolemia and glucose intolerance prediction: Illustration of the application of genomic research to medical practice Atherosclerosis Supplements. 4: 105. DOI: 10.1016/S1567-5688(03)90453-3  0.426
2003 Laberge L, Armstrong L, Brisson D, Lacroix G, Perron P, Gaudet D. 1P-0124 Relationship between sustained attention and metabolic parameters in a monogenic model of susceptibility to type 2 diabetes Atherosclerosis Supplements. 4: 47. DOI: 10.1016/S1567-5688(03)90199-1  0.467
2002 Brisson D, Ledoux K, Bossé Y, St-Pierre J, Julien P, Perron P, Hudson TJ, Vohl MC, Gaudet D. Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients. Pharmacogenetics. 12: 313-20. PMID 12042669 DOI: 10.1097/00008571-200206000-00007  0.705
2002 Brisson D, Houde G, St-Pierre J, Vohl M, Mathieu J, Gaudet D. The pleiotropic expression of the myotonic dystrophy protein kinase gene illustrates the complex relationships between genetic, biological and clinical covariates of male aging The Aging Male. 5: 223-232. DOI: 10.1080/Tam.5.4.223.232  0.68
2001 Brisson D, Vohl MC, St-Pierre J, Hudson TJ, Gaudet D. Glycerol: a neglected variable in metabolic processes? Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 23: 534-42. PMID 11385633 DOI: 10.1002/Bies.1073  0.651
2001 St-Pierre J, Vohl MC, Brisson D, Perron P, Després JP, Hudson TJ, Gaudet D. A sequence variation in the mitochondrial glycerol-3-phosphate dehydrogenase gene is associated with increased plasma glycerol and free fatty acid concentrations among French Canadians. Molecular Genetics and Metabolism. 72: 209-17. PMID 11243726 DOI: 10.1006/Mgme.2000.3144  0.682
2000 Vigneault A, Brisson D, Bélanger C, Gaudet D. Community genetics in Eastern Québec: The experience of the Corporation for Research and Action on Hereditary Diseases Community Genetics. 3: 151-155. DOI: 10.1159/000051128  0.456
Show low-probability matches.